- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 243/24 - Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
Patent holdings for IPC class C07C 243/24
Total number of patents in this class: 16
10-year publication summary
|
2
|
3
|
1
|
0
|
2
|
1
|
0
|
1
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 458 |
4 |
| Abrexa Pharmaceuticals, Inc. | 17 |
2 |
| 3m Innovative Properties Company | 17819 |
1 |
| Hewlett-Packard Development Company, L.P. | 25881 |
1 |
| Industry-University Cooperation Foundation Sogang University | 193 |
1 |
| NDSU Research Foundation | 243 |
1 |
| Oregon Health & Science University | 761 |
1 |
| Sika Technology AG | 2870 |
1 |
| Synta Pharmaceuticals Corp. | 177 |
1 |
| Three Bond Co., Ltd. | 224 |
1 |
| Cukurova Universitesi Rektorlugu | 59 |
1 |
| Changsha Adesso Advanced Materials Corporation Limited | 3 |
1 |
| Other owners | 0 |